• EZH2 Inhibition Targets HPV-Driven Cervical Cancer Progressi

  2026-06-03

  This study demonstrates that EZH2 inhibitors, including EPZ-6438, suppress HPV-associated cervical cancer cell proliferation by downregulating oncogenic pathways and restoring tumor suppressor activity. These findings suggest a promising, less toxic alternative to conventional chemotherapy for HPV-driven malignancies.

• Ertugliflozin (PF-04971729): Precision SGLT2 Inhibition in R

  2026-06-03

  Ertugliflozin (PF-04971729) delivers unparalleled selectivity in SGLT2 inhibition, empowering metabolic and cardiovascular disease modeling with reproducible results. This guide translates the latest cardiometabolic research into actionable protocols and troubleshooting insights for advanced experimental workflows.

• Optimizing Protein Analysis with Lambda Protein Phosphatase

  2026-06-02

  Lambda Protein Phosphatase (RNase-free) from APExBIO empowers precise validation of phosphorylation sites and antibody specificity in dynamic systems like circadian biology. Its dual-specificity, high purity, and robust Mn²⁺-dependent activity streamline workflows for studying protein phosphorylation and post-translational regulation.

• EPZ-6438: Potent EZH2 Inhibitor for Epigenetic Cancer Resear

  2026-06-02

  EPZ-6438 is a highly selective EZH2 inhibitor with nanomolar potency, enabling precise modulation of H3K27me3 in cancer models. Its efficacy in HPV-driven cervical cancer and EZH2-mutant lymphomas is supported by robust peer-reviewed evidence. As supplied by APExBIO, EPZ-6438 advances epigenetic research workflows through reproducible and mechanism-based activity.

• Sumatriptan Succinate: Protocol Innovations in 5-HT1 Researc

  2026-06-01

  Sumatriptan Succinate empowers researchers with a selective and robust approach to dissect serotonergic signaling and migraine pathophysiology. This guide spotlights optimized protocols, troubleshooting strategies, and novel pediatric emergency findings that differentiate APExBIO’s offering for advanced translational and bench research.

• STING agonist-1: Precision Tool for B Cell Immunity Studies

  2026-06-01

  STING agonist-1 empowers researchers to dissect STING pathway activation in B cells, enabling deeper mechanistic insight for cancer immunotherapy research. This guide covers experimental design, troubleshooting, and protocol optimization based on the latest translational breakthroughs.

• Red Blood Cell Lysis Buffer: Precision in Erythrocyte Remova

  2026-05-31

  Unlock new levels of sample purity with Red Blood Cell Lysis Buffer, empowering reproducibility across flow cytometry, nucleic acid, and protein extraction. Discover how APExBIO's ammonium chloride-based solution underpins advanced workflows and research breakthroughs, including those in osteoblastic differentiation.

• Protoporphyrin IX: Optimizing Photodynamic and Ferroptosis A

  2026-05-30

  Protoporphyrin IX empowers researchers to dissect heme biosynthesis, iron metabolism, and ferroptosis resistance—crucial for advancing photodynamic cancer diagnostics and therapy. This guide details how to implement APExBIO’s high-purity Protoporphyrin IX in robust experimental workflows, troubleshoot common pitfalls, and leverage mechanistic insights from the latest hepatocellular carcinoma research.

• Sumatriptan Succinate: Anti-Inflammatory Pathways and Next-G

  2026-05-29

  Explore the advanced pharmacology of Sumatriptan Succinate as a 5-HT1 receptor agonist, with a focus on its anti-inflammatory actions and translational impact for migraine research. This article uniquely examines sumatriptan’s role in inflammation modulation, setting it apart from existing migraine-centric content.

• Synergistic CDK4/6 and BET Inhibition Suppresses PDAC EMT an

  2026-05-29

  Gu et al. demonstrate that combined inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) tumor growth and epithelial-mesenchymal transition (EMT) by modulating GSK3β-mediated Wnt/β-catenin and TGF-β/Smad signaling. This mechanistic insight supports rational design of multi-targeted strategies for aggressive pancreatic cancer, and informs EMT-targeted research workflows.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Verifiable P

  2026-05-28

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables efficient, customizable synthesis of Cy5-labeled RNA probes for sensitive fluorescence-based detection. This Cy5 RNA labeling kit delivers high yield and labeling density suitable for in situ hybridization and Northern blotting applications. Core performance and workflow parameters are supported by peer-reviewed evidence and manufacturer data.

• NPT1-Mediated Renal Transport of Faropenem and Organic Anion

  2026-05-28

  This article discusses the pivotal finding that human NPT1, a renal apical membrane transporter, mediates the transport of p-aminohippuric acid (PAH) and several organic anions, including faropenem. The study provides the first molecular evidence for NPT1’s role in organic anion secretion, with significant implications for antibiotic pharmacokinetics and renal drug handling.

• HDAC6-Catalyzed α-Tubulin Lactylation Regulates Microtubules

  2026-05-27

  This study uncovers HDAC6 as a primary enzyme catalyzing lactylation of α-tubulin at lysine 40, linking metabolic state to cytoskeleton regulation. The findings establish a new post-translational modification that enhances microtubule dynamics and neurite outgrowth, with important implications for neuronal development and cell cycle research.

• Minoxidil Sulphate in Vascular Biology: Protocols & Workflow

  2026-05-27

  Minoxidil sulphate unlocks new precision in vascular and hair growth research thanks to its high solubility, purity, and unique mechanism as a potassium channel opener. This article delivers stepwise workflows, troubleshooting strategies, and comparative guidance—empowering researchers to design robust, reproducible experiments using APExBIO’s trusted compound.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-05-26

  GKT137831 stands out as a dual NADPH oxidase Nox1/Nox4 inhibitor, enabling precise modulation of reactive oxygen species in advanced models of vascular remodeling, fibrosis, and atherosclerosis. This article explores optimized workflows, troubleshooting strategies, and cross-disciplinary uses, grounded in recent breakthroughs in membrane biology and ferroptosis.

16438 records 1/1096 page Next 12345 下5页 Last page